People dependent on alcohol who undergo detoxification commonly relapse into further drinking, despite rehabilitation measures. Acamprosate (Campral EC-Lipha) was launched in the UK in 1996 to be used, with counselling, in maintaining abstinence after alcohol withdrawal in patients with known dependence. Here we review its effects.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.